Lise Eckhoff
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
- COVID-19 and healthcare impacts
- Dermatology top 5%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 10
- COVID-19 and healthcare impacts 2
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
- Cancer Diagnosis and Treatment 1
-
- Chemotherapy-related skin toxicity 2
- Co-authors
- Marianne Ewertz (4 shared papers)Camilla Qvortrup (2 shared papers)Ann Søegaard Knoop (4 shared papers)M. K. Jensen (1 shared paper)Per Pfeiffer (2 shared papers)Martin Bach Jensen (1 shared paper)Bent Ejlertsen (1 shared paper)Søren Feddersen (2 shared papers)
In The Last Decade
Lise Eckhoff
16 papers receiving 762 citations
Peers
Comparison fields: 5 of 74
- Oncology 527
- Dermatology 100
- Hematology 71
- Pharmacology 36
- Physiology 85
Countries citing papers authored by Lise Eckhoff
This map shows the geographic impact of Lise Eckhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lise Eckhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lise Eckhoff more than expected).
Fields of papers citing papers by Lise Eckhoff
This network shows the impact of papers produced by Lise Eckhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lise Eckhoff. The network helps show where Lise Eckhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Lise Eckhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 177 | |
| 2 | 2014 | 132 | |
| 3 | 2014 | 80 | |
| 4 | 2013 | 74 | |
| 5 | 2006 | 72 | |
| 6 | 2020 | 48 | |
| 7 | 2014 | 45 | |
| 8 | 2012 | 38 | |
| 9 | 2011 | 35 | |
| 10 | 2012 | 28 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 14 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2023 | 3 |
About Lise Eckhoff
Lise Eckhoff is a scholar working on Oncology, Dermatology, Hematology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 778 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Chemotherapy-related skin toxicity (2 papers), COVID-19 and healthcare impacts (2 papers), HER2/EGFR in Cancer Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Diagnosis and Treatment (1 paper) and Cannabis and Cannabinoid Research (1 paper). The work is most often cited by research in Oncology (527 citations), Dermatology (100 citations), Hematology (71 citations), Pharmacology (36 citations) and Physiology (85 citations). Lise Eckhoff has collaborated with scholars based in Denmark, Australia and Germany. Frequent co-authors include Marianne Ewertz, Camilla Qvortrup, Ann Søegaard Knoop, M. K. Jensen, Per Pfeiffer, Martin Bach Jensen, Bent Ejlertsen, Søren Feddersen, Troels K. Bergmann and Søren Hein Sindrup. Their work appears in journals such as Acta Oncologica, European Journal of Cancer, Journal of Clinical Medicine, Supportive Care in Cancer and European Journal of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.